Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SLC25A37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SRD5A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGFEM1P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GSG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GPD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXW11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNORD65 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CAMSAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GMDS-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIWIL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SMIM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SORCS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LRRC4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR1D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM175A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DUOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on